Replies to post #421097 on Amarin Corp Plc (AMRN)

[JRoon71]

Good to know. Thx.

Now let's just hope they can take advantage of it!

[ziploc_1]

The article by TalShu on a new drug from Amarin, LR-EtEPA ...posted on August 2023(post# 414421) describes a potential successor to Vascepa...I hope we hear more in the near future about his new, improved, Amarin drug.

A short summary..."Based on 9 U.S. Provisional Patent Applications, Amarin has secured a worldwide patent priority claim to a lymph-releasing composition of eicosapentaenoic acid ethyl ester (LR-EtEPA) technology/invention and methods of using the same to increase EPA uptake in tissues to treat and/or prevent the onset of a number of diseases including:

- Cardiopulmonary, cardiovascular, and cerebrovascular diseases
- Pulmonary disease including sepsis, SIRS, and/or ARDS
- Neurological diseases
- Cancer
- Diseases associated with the kidneys, pancreas, liver, intestines, blood cells, lymph, and the musculoskeletal system
- Diseases associated with oxidative stress and/or glutathione (GSH) depletion
- Inflammation and diseases induced by air pollution
ETC......."

[Tatsumaki]

No it isnt. They're both MND-2119. Go read the actual patents. Put the patented formulations side by side (or go back and find the post where I did just that). They're the same. Same ranges. Same proposed emulsifiers. The new patent may expand on additional uses and describe in more detail mechanisms of adsorption, but at the end of the day it's MND-2119.